Risk Evaluation of N -Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates
Organic Process Research & Development · 16.08.2024 · 28 (8) · 3085-3093
DOI: 10.1021/acs.oprd.4c00255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 25.07.2024. Verfasst von Osama Chahrour und 12 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chahrour, O., Bulger, P. G., Dirat, O., Schrier, K., Parsons, A. T., Ford, J. G., Bernardoni, F., Hetrick, E. M., Bonaga, L. R., Cole, K. P., Miller, J., Zhang, Q., & Jones, M. T. (2024). Risk Evaluation of N -Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates. Organic Process Research & Development, 28(8), 3085-3093. https://doi.org/10.1021/acs.oprd.4c00255
Vancouver
Chahrour O, Bulger PG, Dirat O, Schrier K, Parsons AT, Ford JG, et al. Risk Evaluation of N -Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates. Organic Process Research & Development. 2024;28(8):3085-3093. doi:10.1021/acs.oprd.4c00255
BibTeX
@article{Chahrour2024,
author = {Chahrour, Osama and Bulger, Paul G. and Dirat, Olivier and Schrier, Kate and Parsons, Andrew T. and Ford, J. Gair and Bernardoni, Frank and Hetrick, Evan M. and Bonaga, Llorente R. and Cole, Kevin P. and Miller, Joy and Zhang, Qunying and Jones, Michael T.},
title = {Risk Evaluation of N -Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates},
journal = {Organic Process Research & Development},
year = {2024},
volume = {28},
number = {8},
pages = {3085--3093},
doi = {10.1021/acs.oprd.4c00255}
}
EUVIMED